BioSpace News Archive

Increasing focus on research on chronic ailments will drive antibody labelling services applications

Increasing demand for pharmaceutical containers and biohazard containers to create wide opportunities for medical waste containers market

Advanced glycation end products (AGEs) are a group of compounds that are usually developed via non-enzymatic reactions which occur between the carbonyl groups of reducing sugars & the free lipids, amino groups of proteins, or nucleic acids.

Rapidly advancing seven pipeline programs, including three worldwide, with best-in-class potential in autoimmune and rare diseases

Dassault Systèmes is helping the Pitié-Salpêtrière AP-HP hospital in Paris evaluate airborne coronavirus infection risks in intensive care units, cafeterias and other areas

Biofidelity Ltd, the cancer diagnostics company, announces that the first peer review article detailing its novel ASPYRE™ technology has been published in Scientific Reports, a Nature journal.

Initiated Phase 1 clinical trial for IDE397, a potential best-in-class MAT2A inhibitor for patients having tumors with MTAP-deletion

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that it will host a live conference call and audio webcast on Tuesday, March 30, 2021 at 4:30 p.m. ET to report financial results for the fourth quarter and full-year ended December 31, 2020, and to provide a business overview.

POINT Biopharma Inc. and TerraPower announced they signed a research and clinical supply agreement for the medical radioisotope actinium-225, further expanding the number of radioisotopes in POINT’s pipeline of next-generation precision radiopharmaceutical treatments.

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, announced that the company will participate in panel and corporate presentations at the virtual Life Science Innovation Northwest Conference taking place March 30-31, 2021.